Cargando…

The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden

Background: Mapping can be performed to predict utility values from condition-specific measures when preference-based measures are absent. A previously developed algorithm that predicts EQ-5D-3L index values from the Multiple Sclerosis Impact Scale (MSIS-29) has not yet been externally validated. Ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernstsson, Olivia, Tinghög, Petter, Alexanderson, Kristina, Hillert, Jan, Burström, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132828/
https://www.ncbi.nlm.nih.gov/pubmed/30288416
http://dx.doi.org/10.1177/2381468317692806
_version_ 1783354394931101696
author Ernstsson, Olivia
Tinghög, Petter
Alexanderson, Kristina
Hillert, Jan
Burström, Kristina
author_facet Ernstsson, Olivia
Tinghög, Petter
Alexanderson, Kristina
Hillert, Jan
Burström, Kristina
author_sort Ernstsson, Olivia
collection PubMed
description Background: Mapping can be performed to predict utility values from condition-specific measures when preference-based measures are absent. A previously developed algorithm that predicts EQ-5D-3L index values from the Multiple Sclerosis Impact Scale (MSIS-29) has not yet been externally validated. Aim: To examine the external validity of a previously developed mapping algorithm by testing the accuracy of predicting EQ-5D-3L index values from MSIS-29 among multiple sclerosis (MS) patients in Sweden. Methods: Cross-sectional individual-level data were collected from population-based Swedish registers between 2011 and 2014. Health-related quality of life was assessed through MSIS-29 and EQ-5D-3L at one point in time among 767 individuals with known disability level of MS. A previously developed mapping algorithm was applied to predict EQ-5D index values from MSIS-29 items, and the predictive accuracy was assessed through mean absolute error and root mean square error. Results: When applying the algorithm, the predicted mean EQ-5D-3L index value was 0.77 compared to the observed mean index value of 0.75. Prediction error was higher for individuals reporting EQ-5D values <0.5 compared to individuals reporting EQ-5D values ≥0.5. Mean absolute error (0.12) and root mean square error (0.18) were smaller or equal to the prediction errors found in the original mapping study. Conclusion: The mapping algorithm had similar predictive accuracy in the two independent samples although results showed that the highest predictive performance was found in groups with better health. Varied predictive accuracy in subgroups is consistent with previous studies and strategies to deal with this are warranted.
format Online
Article
Text
id pubmed-6132828
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61328282018-10-04 The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden Ernstsson, Olivia Tinghög, Petter Alexanderson, Kristina Hillert, Jan Burström, Kristina MDM Policy Pract Original Article Background: Mapping can be performed to predict utility values from condition-specific measures when preference-based measures are absent. A previously developed algorithm that predicts EQ-5D-3L index values from the Multiple Sclerosis Impact Scale (MSIS-29) has not yet been externally validated. Aim: To examine the external validity of a previously developed mapping algorithm by testing the accuracy of predicting EQ-5D-3L index values from MSIS-29 among multiple sclerosis (MS) patients in Sweden. Methods: Cross-sectional individual-level data were collected from population-based Swedish registers between 2011 and 2014. Health-related quality of life was assessed through MSIS-29 and EQ-5D-3L at one point in time among 767 individuals with known disability level of MS. A previously developed mapping algorithm was applied to predict EQ-5D index values from MSIS-29 items, and the predictive accuracy was assessed through mean absolute error and root mean square error. Results: When applying the algorithm, the predicted mean EQ-5D-3L index value was 0.77 compared to the observed mean index value of 0.75. Prediction error was higher for individuals reporting EQ-5D values <0.5 compared to individuals reporting EQ-5D values ≥0.5. Mean absolute error (0.12) and root mean square error (0.18) were smaller or equal to the prediction errors found in the original mapping study. Conclusion: The mapping algorithm had similar predictive accuracy in the two independent samples although results showed that the highest predictive performance was found in groups with better health. Varied predictive accuracy in subgroups is consistent with previous studies and strategies to deal with this are warranted. SAGE Publications 2017-02-01 /pmc/articles/PMC6132828/ /pubmed/30288416 http://dx.doi.org/10.1177/2381468317692806 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Ernstsson, Olivia
Tinghög, Petter
Alexanderson, Kristina
Hillert, Jan
Burström, Kristina
The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title_full The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title_fullStr The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title_full_unstemmed The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title_short The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
title_sort external validity of mapping msis-29 on eq-5d among individuals with multiple sclerosis in sweden
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132828/
https://www.ncbi.nlm.nih.gov/pubmed/30288416
http://dx.doi.org/10.1177/2381468317692806
work_keys_str_mv AT ernstssonolivia theexternalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT tinghogpetter theexternalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT alexandersonkristina theexternalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT hillertjan theexternalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT burstromkristina theexternalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT ernstssonolivia externalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT tinghogpetter externalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT alexandersonkristina externalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT hillertjan externalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden
AT burstromkristina externalvalidityofmappingmsis29oneq5damongindividualswithmultiplesclerosisinsweden